Alessandro Santin
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer (NCT03832361) | Alessandro Santin | 2020-07-15 |
Track Alessandro Santin automatically
Every clearance here is in the API, with alerts when new ones post.